| RNA N6‐methyladenosine methyltransferase‐like 3 promotes liver cancer progression through YTHDF2‐dependent posttranscriptional silencing of SOCS2 M Chen, L Wei, CT Law, FHC Tsang, J Shen, CLH Cheng, LH Tsang, ... Hepatology 67 (6), 2254-2270, 2018 | 1145 | 2018 |
| The emerging roles of N6-methyladenosine (m6A) deregulation in liver carcinogenesis M Chen, CM Wong Molecular cancer 19 (1), 44, 2020 | 266 | 2020 |
| Hypoxia regulates the mitochondrial activity of hepatocellular carcinoma cells through HIF/HEY1/PINK1 pathway D Kung-Chun Chiu, A Pui-Wah Tse, CT Law, I Ming-Jing Xu, D Lee, ... Cell death & disease 10 (12), 934, 2019 | 140 | 2019 |
| A survey of optimal strategy for signature-based drug repositioning and an application to liver cancer C Yang, H Zhang, M Chen, S Wang, R Qian, L Zhang, X Huang, J Wang, ... Elife 11, e71880, 2022 | 89 | 2022 |
| Histone chaperone FACT complex mediates oxidative stress response to promote liver cancer progression J Shen, M Chen, D Lee, CT Law, L Wei, FHC Tsang, DWC Chin, ... Gut 69 (2), 329-342, 2020 | 48 | 2020 |
| Bromodomain-containing protein BRPF1 is a therapeutic target for liver cancer CLH Cheng, FHC Tsang, L Wei, M Chen, DWC Chin, J Shen, CT Law, ... Communications Biology 4 (1), 888, 2021 | 28 | 2021 |
| Loss of hepatic FTCD promotes lipid accumulation and hepatocarcinogenesis by upregulating PPARγ and SREBP2 S Wang, Y Zhou, R Yu, J Ling, B Li, C Yang, Z Cheng, R Qian, Z Lin, C Yu, ... JHEP Reports 5 (10), 100843, 2023 | 14 | 2023 |
| Histone chaperone FACT complex coordinates with HIF to mediate an expeditious transcription program to adapt to poorly oxygenated cancers J Shen, C Yang, MS Zhang, DWC Chin, CT Law, G Wang, CLH Cheng, ... Cell reports 38 (5), 2022 | 13 | 2022 |
| Targeting of vulnerabilities of drug-tolerant persisters identified through functional genetics delays tumor relapse M Chen, S Mainardi, C Lieftink, A Velds, I de Rink, C Yang, HJ Kuiken, ... Cell Reports Medicine 5 (3), 2024 | 8 | 2024 |
| Cancer drug-tolerant persister cells: from biological questions to clinical opportunities M Russo, M Chen, E Mariella, H Peng, SK Rehman, E Sancho, A Sogari, ... Nature Reviews Cancer 24 (10), 694-717, 2024 | 2 | 2024 |
| Dysregulations and functions of RNA modifying enzymes METTL3 and TRMT6 in hepatocellular carcinoma M Chen HKU Theses Online (HKUTO), 2019 | 1 | 2019 |
| Up-regulation of METTL3 promoted m6A modification and epigenetic silencing of SOCS2 in human liver cancer M Chen, L Wei, CT Law, FH Tsang, J Shen, CL Cheng, LH Tsang, DW Ho, ... Cancer Research 78 (13_Supplement), 4321-4321, 2018 | | 2018 |
| Deregulation of RNA N6-adenosine methylation contribute to liver carcinogenesis M Chen, LL Wei, CT Law, FHC Tsang, IMJ Xu, JLMF Lee, CWCL Wong, ... Cancer Research 77 (13_Supplement), 1390-1390, 2017 | | 2017 |
| Expression and functions of ASH1L in liver cancer L Wei, FH Tsang, D Ho, CT Law, M Chen, LH Tsang, CC Wong, IO Ng, ... Cancer Research 77 (13_Supplement), 1380-1380, 2017 | | 2017 |
